FDA Adverse Event
Death
Summary report: N
ALLOGRAFT
MDR report key: 562055
·
Received December 21, 2004
Report
- Report Number
- 562055
- Event Type
- Death
- Date Received
- December 21, 2004
- Date of Event
- May 20, 2004
- Report Date
- December 16, 2004
- Manufacturer
- *
- Product Code
- LMO
- Adverse Event
- Yes
- Report Source
- User Facility report
- Reporter Occupation
- NURSE
Narratives
Description of Event or Problem · 1
PT ADMITTED AFTER MVA UNDERWENT A POSTEROLATERAL ARTHRODESIS C4 TO T3, SEGMENTAL PEDICLE FIXATION, C4 TO T3, POSTEROLATRAL ALLOGRAFT C4 TO T3 IN 2004. PT SUBSEQUENTLY WAS DIAGNOSED WITH FULMINANT LIVER FAILURE DURING A 9/2004 ADMISSION AND WAS DIAGNOSED AS HEP B POSITIVE. OF THE RISK FOR HEPATITIS, THE PT WAS AN INSULIN DEPENDENT DIABETIC, SURGERY, TRANSFUSION AND ALLOGRAFT. THE PT RECEIVED DEMINERALIZED BONE MATRIX GRAFTS. EXP DATE 2005 AND EXP DATE 2006. INFECTION CONTROL COORDINATOR REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ALLOGRAFT | ALLOGRAFT | LMO | * | * | 005313751132 | |
| 2 | ALLOGRAFT | ALLOGRAFT | LMO | * | * | 035343311177 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 60 YR | Death |